Please assess the completion status of the following clinical trial:

Trial Title: Cost-utility Analysis of the Use of the Paro Robotic Seal by Elderly Patients With Moderate or Severe Cognitive Disorders in Institutions: a Randomised Study.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients over 70 years of age~* With moderate or severe neurocognitive disorders of any etiology (Mini Mental State Examination (MMSE) less than or equal to 20, or not feasible)~* Resident in EHPAD (establishment for dependent elderly people) or USLD (long-term care unit ) in permanent accommodation for more than 1 month at inclusion~Exclusion Criteria:~* Patient with presumed life expectancy of less than 3 months~* Mini Mental State Examination (MMSE) not feasible for any reason other than cognitive impairment (e.g. stroke aphasia), without dementia~* Known carrier of multi-drug resistant bacteria~* Carrier of Pace-maker (precautionary advice from manufacturer)~* Refusal to participate to the study (trusted person, guardian or curator or patient depending on the patient's mental state)~* Patient under court protection~* Prior inclusion in an interventional study that may alter the interpretation of the results of the analysis~* Patient not affiliated to a social security system or beneficiary of such a system

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- With robotic seal PARO (Type: EXPERIMENTAL): The robot will be made available to the patient by the caregiver in charge of the patient for 5 minutes before a toilet and for the duration of the treatment (about 10 minutes), twice a week for 16 weeks.
- Without robotic seal PARO (Type: NO_INTERVENTION): The care of the patient during the toilet will be carried out according to the modalities currently in use in the facility.

Based on this trial design, predict the completion outcome and termination type (if applicable).